Lanirapid and Rocephin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lanirapid (metildigoxin) and Rocephin (ceftriaxone sodium). Common drug interactions include overdose among females and anorexia among males.

The phase IV clinical study analyzes what interactions people have when they take Lanirapid and Rocephin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Lanirapid?

Lanirapid has active ingredients of metildigoxin. eHealthMe is studying from 1,259 Lanirapid users. Check the latest studies of Lanirapid.

What is Rocephin?

Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.

On Jul, 16, 2026

14 people who take Lanirapid and Rocephin together, and have interactions are studied.

Lanirapid and Rocephin drug interactions.

What are the common drug interactions of Lanirapid and Rocephin, by gender? *:

female:

Overdose
Restlessness (not able to rest)
Erythema multiforme (a type of hypersensitivity reaction)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Rash
Renal failure acute (rapid kidney dysfunction)
Septic shock (shock due to blood infection)
Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

male:

Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Atrioventricular block complete (heart block complete)
Distress
Glycosuria present
Heart rate increased
Hypotension (abnormally low blood pressure)
Ketonuria present
Loss of consciousness
Oxygen saturation decreased
Pleural effusion (water on the lungs)

What are the common drug interactions of Lanirapid and Rocephin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Overdose
Restlessness (not able to rest)
C-reactive protein increased
Depressed level of consciousness
Distress
Erythema multiforme (a type of hypersensitivity reaction)
Glycosuria present
Heart rate increased
Hypotension (abnormally low blood pressure)
Ketonuria present

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 57.14%
Kidney Infection (Pyelonephritis): 3 people, 21.43%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 3 people, 21.43%
Pneumonia: 2 people, 14.29%
Cardiac Failure Congestive: 2 people, 14.29%
Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 7.14%
Stable Angina (a constant chest pain): 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Heart Disease: 1 person, 7.14%
Embolic Stroke (stroke due to obstruction due to an embolus): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Lanirapid and Rocephin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously